I-Mab ADR (IMAB) is around the middle of the Biotechnology industry according to InvestorsObserver. IMAB received an overall rating of 36, which means that it scores higher than 36 percent of all stocks. I-Mab ADR also achieved a score of 34 in the Biotechnology industry, putting it above 34 percent of Biotechnology stocks. Biotechnology is ranked 69 out of the 148 industries.
IMAB has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on IMAB!